Exocure Sweden AB
Exocure pioneers exosome biotechnology for advanced cancer therapeutics.
Oversikt
- Ukjent
- Ansatte
- Ukjent
- Omsetning
- 2023
- Grunnlagt
Nøkkelbeslutningstakere
Helena Lundquist
Board Member
Magnus Käll
CFO
Jan Lötvall
Founder, Board Member, Professor
Mats Persson
Chairman of the Board, Co-Founder
+6 flere kontakter i Funnelfeedr
Beskrivelse
Exocure Sweden AB is an innovative biotechnology company focused on harnessing the potential of exosomes for therapeutic applications. They operate as a platform company, developing proprietary technology and methods to manipulate and manufacture these extracellular vesicles. The core mission is to...
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Tillverkning av läkemedel
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE559427656901
Beslutningstakere
10 kontakter i FunnelfeedrHelena Lundquist
Board Member
Magnus Käll
CFO
Jan Lötvall
Founder, Board Member, Professor
Mats Persson
Chairman of the Board, Co-Founder
Richard Bergström
Board Member
Klementina Österberg
Alternate Board Member
Søren Melsing
CEO
Kyong-su Park
Senior Scientist, Co-founder
Catharina Gustafsson Wallich
Board Member
Andre kontakter
Roger Olofsson Bagge
Scientific Advisor
Lignende bedrifter
20 lignende bedrifter i Funnelfeedr
Isofol Medical AB (publ)
10–19 ansatteDeveloping next-generation folate drug to improve cancer treatment efficacy.
AcroPharma AB (publ)
0 ansatteDeveloping innovative preventive therapeutics for major human diseases.
LIDDS AB
1–4 ansatteSwedish drug delivery company utilizing proprietary NanoZolid technology platform.
NeoTargets AB
5–9 ansatteIdentifying curative cancer targets using a proprietary discovery platform.
Theralia AB
0 ansattePioneering biotech revolutionizing drug delivery via TOUCAN technology.
Spørsmål om Exocure Sweden AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo